 Liposomes
"Liposomes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.
| Descriptor ID |
D008081
|
| MeSH Number(s) |
D25.479.517 D26.255.260.517 J01.637.051.479.517 J01.637.087.500.517
|
| Concept/Terms |
Transferosomes- Transferosomes
- Transferosome
- Ultradeformable Liposomes
- Liposome, Ultradeformable
- Liposomes, Ultradeformable
- Ultradeformable Liposome
- Liposomes, Ultra-deformable
- Liposome, Ultra-deformable
- Liposomes, Ultra deformable
- Ultra-deformable Liposome
- Ultra-deformable Liposomes
|
Below are MeSH descriptors whose meaning is more general than "Liposomes".
Below are MeSH descriptors whose meaning is more specific than "Liposomes".
This graph shows the total number of publications written about "Liposomes" by people in this website by year, and whether "Liposomes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1997 | 1 | 4 | 5 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 3 | 3 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 5 | 6 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 2 | 3 | | 2004 | 1 | 3 | 4 | | 2005 | 1 | 4 | 5 | | 2006 | 4 | 4 | 8 | | 2007 | 0 | 2 | 2 | | 2008 | 2 | 5 | 7 | | 2009 | 3 | 3 | 6 | | 2010 | 1 | 3 | 4 | | 2011 | 1 | 5 | 6 | | 2012 | 2 | 4 | 6 | | 2013 | 2 | 5 | 7 | | 2014 | 4 | 4 | 8 | | 2015 | 2 | 4 | 6 | | 2016 | 0 | 2 | 2 | | 2017 | 4 | 3 | 7 | | 2018 | 0 | 2 | 2 | | 2019 | 2 | 6 | 8 | | 2020 | 1 | 1 | 2 | | 2021 | 2 | 4 | 6 | | 2022 | 2 | 9 | 11 | | 2023 | 2 | 9 | 11 | | 2024 | 4 | 16 | 20 | | 2025 | 1 | 11 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Liposomes" by people in Profiles.
-
Joseph RA, Haley RM, Padilla MS, Ricciardi AS, Yamagata HM, Mitchell MJ. Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Lett. 2025 Oct 01; 25(39):14348-14355.
-
Swingle KL, Hamilton AG, Han X, Liao KC, Safford HC, Thatte AS, Geisler HC, Xu J, Saw TY, Wan Y, Mitchell MJ. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc Natl Acad Sci U S A. 2025 Sep 23; 122(38):e2505718122.
-
Panja S, Zaman LA, Zhang C, Patel M, Gorantla S, Dash PK, Gendelman HE. Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision. Adv Healthc Mater. 2025 Sep; 14(25):e2501190.
-
Ray S, Jacques S, Ettah U, Dai S, Gaikwad HK, Scheinman RI, Mallela KMG, Simberg D. Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies. Mol Pharm. 2025 Aug 04; 22(8):4909-4918.
-
Vadovics M, Zhao W, Daley EF, Lam K, Daly O, Rashid K, Lee HR, Schreiner P, Lundgreen KA, Gaudette BT, Shuvaev VV, Arguiri E, Muramatsu H, Sárközy A, Mdluli T, Xu J, Han X, De Luna N, Castaño D, Bettini E, Ábrahám E, Lipinszki Z, Carlucci G, Bansode AH, Nguyen K, Le TM, Luu T, Muzykantov VR, Bates P, Allman D, Mitchell MJ, Locci M, Radu CG, Heyes J, Pardi N. Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat Nanotechnol. 2025 Sep; 20(9):1312-1322.
-
Aunins EA, Phan AT, Alameh MG, Dwivedi G, Cruz-Morales E, Christian DA, Tam Y, Bunkofske ME, Peñafiel AZ, O'Dea KM, Merolle M, Furey C, Scott P, Vonderheide RH, Hensley SE, Kedl RM, Weissman D, Hunter CA. An Il12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses. Sci Immunol. 2025 06 06; 10(108):eads1328.
-
Shin JE, Won EJ, Xu J, Lee JC, Bang JK, Mitchell MJ, Cha-Molstad H. Transition Temperature-Guided Design of Lipid Nanoparticles for Effective mRNA Delivery. ACS Appl Mater Interfaces. 2025 May 14; 17(19):28012-28024.
-
Haley RM, Padilla MS, El-Mayta RD, Joseph RA, Weber JA, Figueroa-Espada CG, Mukalel AJ, Ricciardi AS, Palanki R, Geisler HC, Jester MT, Davidson BL, Mitchell MJ. Lipid Nanoparticles for In Vivo Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets. ACS Nano. 2025 04 15; 19(14):13790-13804.
-
Safford HC, Shuler CF, Geisler HC, Thatte AS, Swingle KL, Han EL, Murray AM, Hamilton AG, Yamagata HM, Mitchell MJ. Probing the Role of Lipid Nanoparticle Elasticity on mRNA Delivery to the Placenta. Nano Lett. 2025 03 26; 25(12):4800-4808.
-
Padilla MS, Mrksich K, Wang Y, Haley RM, Li JJ, Han EL, El-Mayta R, Kim EH, Dias S, Gong N, Teerdhala SV, Han X, Chowdhary V, Xue L, Siddiqui Z, Yamagata HM, Kim D, Yoon IC, Wilson JM, Radhakrishnan R, Mitchell MJ. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat Commun. 2025 Jan 24; 16(1):996.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|